01 Shift toward Doppler-Guided Hemorrhoidal Artery Ligation Doppler-guided hemorrhoidal artery ligation is emerging as a highly specialized hemorrhoid treatment market trend due to its ability to reduce postoperative pain while preserving anal anatomy. Healthcare providers are increasingly adopting this technique for Grade II and III hemorrhoids as an alternative to conventional excisional surgery. For instance, THD S.p.A. continues expanding the adoption of its THD Doppler systems, which use real-time arterial mapping to precisely identify and ligate hemorrhoidal arteries, supporting procedure-specific innovation and improving patient recovery outcomes.
02 Growing Adoption of Radiofrequency Ablation-based Hemorrhoid Procedures Radiofrequency ablation is gaining traction as a key hemorrhoid treatment market trend owing to shorter procedure times, reduced tissue trauma, and faster return to normal activities. The technology delivers controlled thermal energy directly to hemorrhoidal tissue while preserving surrounding tissue integrity. Clinical studies have reported lower postoperative pain scores and reduced recovery periods compared with conventional hemorrhoidectomy, supporting increasing adoption of radiofrequency-based procedures in ambulatory surgical centers and specialized colorectal treatment facilities.
01 The hemorrhoid treatment market forecasts a gradual increase in investment activity driven by the rising prevalence of hemorrhoidal disorders, growing demand for minimally invasive treatment procedures, and increasing adoption of advanced colorectal care technologies. The growing burden of sedentary lifestyles, obesity, chronic constipation, and aging populations continues to support investor interest in gastrointestinal and proctology-focused healthcare companies.
02 Key Investment and Funding Activities in Hemorrhoid Treatment Market, 2025 Company Recent Activity Timeline Details E2 Medical Funding Round of USD 80 million May 2026 E2 Medical raised approximately USD 80 million to advance commercialization of its minimally invasive thrombectomy platform and expand interventional treatment technologies, reflecting continued investor interest in procedural medical-device innovation. Earendil Labs Financing Round of USD 787 million March 2026 Earendil Labs secured approximately USD 787 million in financing to expand AI-driven therapeutic research and biologics development, highlighting strong funding momentum across advanced treatment technology platforms relevant to broader healthcare markets.
01 Increasing Use of Anticoagulant Therapies and Growing Focus on Postpartum Hemorrhoid Management Drives Market The increasing use of anticoagulants and antiplatelet medications among elderly cardiovascular patients is driving demand for low-bleeding-risk hemorrhoid interventions. Conventional hemorrhoidectomy may require medication adjustments, whereas procedures such as Doppler-guided hemorrhoidal artery ligation and sclerotherapy offer less invasive alternatives. As global populations age and long-term anticoagulant use rises, healthcare providers are increasingly adopting treatment approaches designed for this specific patient cohort, supporting hemorrhoid treatment market growth.The growing emphasis on postpartum hemorrhoid care is a significant market driver for hemorrhoid treatment demand. Hemorrhoids frequently develop during pregnancy and after childbirth due to increased pelvic pressure, hormonal changes, and delivery-related straining. For example, various NHS maternity trusts in the UK expanded postnatal pelvic health services that include assessment and management of anorectal conditions such as hemorrhoids, reflecting greater clinical attention to postpartum recovery. This increased focus on maternal anorectal health is contributing to higher utilization of hemorrhoid medications and minimally invasive treatment procedures.
01 Patient Reluctance toward Early Clinical Consultation and Limited Reimbursement for Office-based Hemorrhoid Procedures Restrain Market Hemorrhoidal symptoms are frequently underreported because patients often delay seeking medical attention due to embarrassment, social stigma, and fear of anorectal examinations. Many individuals initially rely on self-care measures or over-the-counter remedies, postponing professional treatment until symptoms worsen. This delay reduces early intervention rates and limits utilization of prescription therapies and office-based procedures, creating a significant restraint on market expansion.Various minimally invasive hemorrhoid treatments, including Doppler-guided hemorrhoidal artery ligation and radiofrequency ablation, face inconsistent reimbursement coverage across healthcare systems. Reimbursement disparities increase out-of-pocket expenses and discourage adoption despite favorable clinical outcomes. Many healthcare providers continue using conventional approaches because newer procedural options may not receive equivalent compensation. This reimbursement gap slows technology penetration and restricts broader commercialization of advanced hemorrhoid treatment modalities.
01 Increasing Adoption of AI-assisted Anorectal Imaging and Expansion of Women's Pelvic Health Clinics Offer Growth Opportunities for Hemorrhoid Treatment Market Players The use of AI-assisted anorectal imaging and diagnostic platforms in colorectal practice is creating a significant growth opportunity. Advanced image-analysis systems help physicians identify hemorrhoidal disease severity more accurately, improving treatment selection and reducing diagnostic variability. For example, AI-enabled endoscopic assessment tools are increasingly used in gastroenterology centers to support earlier detection of anorectal abnormalities. This technological integration is expected to increase procedural volumes and utilization of targeted hemorrhoid treatment solutions.The rapid growth of specialized women's pelvic health and postpartum recovery clinics is creating opportunities for hemorrhoid treatment providers. These centers increasingly manage pregnancy-related anorectal disorders alongside pelvic floor rehabilitation and maternal wellness services. For example, the UK's NHS Long Term Plan continues expanding Perinatal Pelvic Health Services (PPHS) across England, providing structured postpartum assessment pathways for pelvic and anorectal conditions. The broader integration of postpartum pelvic health care is improving diagnosis rates and increasing referrals for hemorrhoid medications and minimally invasive procedures.
01 Lack of Standardized Treatment Selection Pathways and Limited Specialist Availability Challenges Hemorrhoid Treatment Market Growth Treatment decisions for hemorrhoidal disease often vary significantly between colorectal surgeons, gastroenterologists, and proctologists due to the availability of multiple procedural and pharmacological options. Similar-grade hemorrhoids may receive different treatments across healthcare facilities, creating inconsistency in patient management. This variability complicates technology adoption, limits procedural standardization, and creates challenges for manufacturers seeking broader clinical acceptance of newer hemorrhoid treatment modalities.Advanced hemorrhoid treatments such as Doppler-guided hemorrhoidal artery ligation, stapled hemorrhoidopexy, and radiofrequency ablation require specialized training and procedural expertise. However, access to experienced colorectal specialists remains uneven across many healthcare systems. This shortage restricts patient access to advanced interventions, prolongs waiting times, and limits the utilization of newer treatment technologies, creating a significant challenge for market expansion and procedural adoption.
April 2026 Medtronic strengthened its surgical solutions portfolio by launching next-generation hemorrhoid treatment devices featuring improved precision, tissue preservation, and faster postoperative recovery.
February 2026 Olympus Corporation expanded its gastrointestinal endoscopy portfolio with enhanced visualization and therapeutic technologies supporting minimally invasive diagnosis and treatment of hemorrhoidal disease.
September 2025 Cook Medical introduced upgraded anorectal intervention devices designed to improve the safety and effectiveness of minimally invasive hemorrhoid procedures in hospital and outpatient settings.
May 2025 B. Braun strengthened its colorectal surgery portfolio by expanding advanced surgical instruments and treatment solutions supporting hemorrhoid management and other anorectal procedures.